Showing results (481-490 of 634) with videos related to
Sort By:
Pageof 64
Marine Pollution Bulletin|February 26, 2023
Microplastics in large marine animals stranded in the Republic of KoreaByeongyong Park, Seung-Kyu Kim, Soobin Joo, et al.International Journal of Radiation Oncology, Biology, Physics|May 11, 2010
Phase I study of preoperative chemoradiation with s-1 and oxaliplatin in patients with locally advanced resectable rectal cancerYong Sang Hong, Jae-Lyun Lee, Jin Hong Park, et al.Clinical Colorectal Cancer|July 29, 2014
Randomized phase II open-label study of mFOLFOX6 in combination with linifanib or bevacizumab for metastatic colorectal cancerBert H O'Neil, Calin Cainap, Eric Van Cutsem, et al.International Journal of Radiation Oncology, Biology, Physics|October 12, 2010
Randomized trial of postoperative adjuvant therapy in Stage II and III rectal cancer to define the optimal sequence of chemotherapy and radiotherapy: 10-year follow-upTae-Won Kim, Je-Hwan Lee, Jung-Hee Lee, et al.Plos One|June 23, 2012
YM155 induces EGFR suppression in pancreatic cancer cellsYoung-Soon Na, Soo-Jin Yang, Seung-Mi Kim, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 28, 2013
3'-Deoxy-3'-18F-fluorothymidine PET for the early prediction of response to leucovorin, 5-fluorouracil, and oxaliplatin therapy in patients with metastatic colorectal cancerYong Sang Hong, Hye Ok Kim, Kyu-pyo Kim, et al.The Lancet. Oncology|April 21, 2019
Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trialCathy Eng, Tae Won Kim, Johanna Bendell, et al.Clinical and Molecular Hepatology|April 3, 2015
Fibroblast growth factor receptor isotype expression and its association with overall survival in patients with hepatocellular carcinomaHyo Jeong Lee, Hyo Jeong Kang, Kang Mo Kim, et al.International Journal of Radiation Oncology, Biology, Physics|August 18, 2017
Total Mesorectal Excision Versus Local Excision After Favorable Response to Preoperative Chemoradiotherapy in "Early" Clinical T3 Rectal Cancer: A Propensity Score AnalysisYoung Seob Shin, Chang Sik Yu, Jin-Hong Park, et al.Oncology|May 5, 2012
A Phase II study of clinical outcomes of 3-week cycles of irinotecan and S-1 in patients with previously untreated metastatic colorectal cancer: influence of the UGT1A1 and CYP2A6 polymorphisms on clinical activityYoon Hee Choi, Tae Won Kim, Kyu-Pyo Kim, et al.Pageof 64